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PRELIMINARY AND SHORT REPORT
MACNAMYCIN IN THE TREATMENT OF GRANULOMA INGUINALE5
HARRY M. RoBINsoN, Ja., MI). AND MORRIS M. COHEN, M.D
The efficacy of the broad spectrum antibiotics, streptomycin and dihydrostreptomycin
in the treatment of granuloma inguinale has been repeatedly demonstrated. When these
drugs are used, Donovan bodies will disappear from the lesions in from 5 to 9 days after
the initiation of therapy and prompt healing of the lesions results. The time necessary for
the involution of the granulomatous process depends on the severity and extent of the con-
dition. The results obtained with these drugs has stimulated us to investigate the value of
magnamycin in the treatment of granuloma inguinale.
TABLE I
Magnamycin is an antibiotic derived from Streptomyces halstedii. It is a white crystalline
substance which is supplied for oral administration in 100 and 250 mgm. enteric coated
tablets. Tanner and associates (1), demonstrated its effectivity against Rickettsiae. This
antibiotic has been found to have a low degree of toxicity in animals (2). Whitaker, et al.
(3) had demonstrated the therapeutic value of magnamycin in the treatment of five patients
with granuloma inguinale.
Six patients, a1i negroes were included in this study. Two of these were female and four
were male and all of these individuals had clinical evidence of granuloma inguinale. The
diagnosis was evidenced in each instance by discovery of Donovan bodies in a stained
preparation from marginal scrapings.
TREATMENT SCHEDULES
One patient was given 239 mg. every 6 hours; one was given 259 mg. every 6 hours; and
four received 300 mg. every 6 hours (See Table I).
RESULTS
Complete healing was noted in all 6 patients. The response to treatment varied with the
duration and extent of the condition. The shortest length of time to produce complete heal-
26%
EXTENT OF LESIONS DOSAGESCHEDULE
CASE
NUM-
BER
1
2
3
4
5
6
TOTAL
DOSE
IN
GRAMS
DATE OF
ADMISSION
5/25/53
6/10/53
6/8/53
8/16/53
7/1/53
8/3/53
DATE OF VERSE
HEALING RE-
ACTIONS
Large ulcer on right is- 200mgmevery6hours
bium majus
Destruction of glans penis 300 mgm every 6 hours
Granulomatous lesion on 300 mgm every 6 hours
left labium majus
Large ulcer on ventral 300 mgm ever\' 6 hours
surface of penis
Several granulomatous 300 mgm every 6 hours
ulcers on penis
Destruction of glans 2somgmevery6hours
penis
16.8
15.0
10.8
22.5
17.5
23.5
6/15/53 none
7/13/53 none
6/17/53 none
9/16/53 none
7/17/53 none
9/16/53 none
* From the University of Maryland Department of Dermatology.
This study was supported by a grant-in-aid from the Charles Pfizer Company of Brook-
lyn, New York. The magnamycin was supplied by Dr. Alan Wright.
Received for publication November 24, 1953.
264 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
ing was 9 days and the greatest length of time was 41 days. No adverse reactions were
encountered.
SUMMARY AND CONCLUSION
1. Nine patients with granuloma inguinale were treated with magnamyCin using enteric
coated tablets.
2. No relapses have been noted.
3. All 6 patients obtained a satisfactory result with complete healing of the lesions and
no relapses have been noted in a follow up period from one to three months.
4. Magnamycin is of definite value in the treatment of granuloma inguinale. No adverse
reactions were encountered.
5. The optimum dose has not as yet been established.
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